Menu
Curie Logo
Donate
  • Home >
  • Publications >
  • Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity

Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity

1 Apr 2017Cancer/Radiothérapie

DOI : 10.1016/j.canrad.2016.10.002

Authors

Z. Ajgal, S. de Percin, V. Diéras, J.Y. Pierga, F. Campana, A. Fourquet, Y.M. Kirova